As of 2026-04-13, the Intrinsic Value of XBiotech Inc (XBIT) is -7.47 USD. This XBIT valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.33 USD, the upside of XBiotech Inc is -420.51%.
Based on its market price of 2.33 USD and our intrinsic valuation, XBiotech Inc (XBIT) is overvalued by 420.51%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.47 - -7.47 | -7.47 | -420.51% |
| P/E | (25.30) - (31.31) | (27.82) | -1293.9% |
| DDM - Stable | (7.87) - (25.76) | (16.82) | -821.7% |
| DDM - Multi | (5.23) - (14.61) | (7.86) | -437.3% |
| Market Cap (mil) | 71.04 |
| Beta | 1.39 |
| Outstanding shares (mil) | 30.49 |
| Enterprise Value (mil) | -54.51 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.25% |
| Cost of Debt | 5.00% |
| WACC | 9.03% |